R1 RCM builds AI and automation technology for the healthcare revenue cycle, including the Phare Revenue Operating System and the R37 AI lab.
R1 RCM builds enterprise-grade AI and automation technology for the healthcare revenue cycle, with the stated aim of helping providers get paid faster and freeing them to concentrate on patient care. Its technical work spans artificial intelligence, agentic AI, automation and real-time adjudication systems. The company operates in the United States and works with hospitals and health systems on payer-provider administration.
Two products frame the engineering agenda. Phare is described as healthcare's first Revenue Operating System: it applies agentic AI to enable real-time adjudication, align payer and provider incentives and reduce administrative drag. R37 is R1's dedicated AI lab, tasked with developing new solutions to push the industry towards comprehensive automation. The company reports partnerships with 95 of the top 100 US health systems and 20 years of operator experience.
R1 reports that its clients have recovered more than $6bn in annual revenue, with a 5–7% yield boost and a 50% reduction in cost to collect, alongside 200m+ tasks automated. The company places the annual cost of the broken revenue cycle at $500bn drained from the healthcare system. It describes itself as mission-driven, with an emphasis on combining deep domain expertise with enterprise-grade technology and on measurable outcomes.
